-
1
-
-
0026655474
-
Bcl-2 initiates a new category of oncogenes: Regulators of cell death
-
Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879-886, 1992.
-
(1992)
Blood
, vol.80
, pp. 879-886
-
-
Korsmeyer, S.J.1
-
2
-
-
0026353797
-
All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment
-
Gribben JG, Freedman AS, Woo SD, Blake K, Shu RS, Freeman G, Longtine JA, Pinkus GS, Nadler LM: All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275-3280, 1991.
-
(1991)
Blood
, vol.78
, pp. 3275-3280
-
-
Gribben, J.G.1
Freedman, A.S.2
Woo, S.D.3
Blake, K.4
Shu, R.S.5
Freeman, G.6
Longtine, J.A.7
Pinkus, G.S.8
Nadler, L.M.9
-
3
-
-
0028083854
-
Detection and quantitation of low numbers of chromosomes containing bcl-2 oncogene translocations using seminested PCR
-
Zhang X-Y, Ehrlich M: Detection and quantitation of low numbers of chromosomes containing bcl-2 oncogene translocations using seminested PCR. BioTechniques 16:502-507, 1994.
-
(1994)
BioTechniques
, vol.16
, pp. 502-507
-
-
Zhang, X.-Y.1
Ehrlich, M.2
-
4
-
-
0029665393
-
H rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases
-
H rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol 14:1333-1344, 1996.
-
(1996)
J Clin Oncol
, vol.14
, pp. 1333-1344
-
-
Dölken, G.1
Illerhaus, G.2
Hirt, C.3
Mertelsmann, R.4
-
5
-
-
0028295023
-
Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma
-
Johnson PWM, Price CGA, Smith T, Cotter FE, Meerabux J, Rohatiner AZS, Young BD, Lister TA: Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol 12:798-805, 1994.
-
(1994)
J Clin Oncol
, vol.12
, pp. 798-805
-
-
Johnson, P.W.M.1
Price, C.G.A.2
Smith, T.3
Cotter, F.E.4
Meerabux, J.5
Rohatiner, A.Z.S.6
Young, B.D.7
Lister, T.A.8
-
6
-
-
0028606361
-
BCL2 translocation frequency rises with age in humans
-
Liu Y, Hernandez AM, Shibata D, Cortopassi GA: BCL2 translocation frequency rises with age in humans: Proc Natl Acad Sci USA 91: 8910-8914, 1994.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 8910-8914
-
-
Liu, Y.1
Hernandez, A.M.2
Shibata, D.3
Cortopassi, G.A.4
-
7
-
-
0029039424
-
H translocations in human blood and organ samples by a quantitative polymerase chain reaction assay
-
H translocations in human blood and organ samples by a quantitative polymerase chain reaction assay. Cancer Res 55:2876-2882, 1995.
-
(1995)
Cancer Res
, vol.55
, pp. 2876-2882
-
-
Ji, W.1
Qu, G.2
Ye, P.3
Zhang, X.4
Halabi, S.5
Ehrlich, M.6
-
8
-
-
0027141324
-
Rearrangement of bcl-2 gene in follicular lymphoma: Detection by PCR in both fresh and fixed tissue samples
-
Liu J, Johnson RM, Traweek T: Rearrangement of bcl-2 gene in follicular lymphoma: Detection by PCR in both fresh and fixed tissue samples. Diagn Mol Pathol 2:241-247, 1993.
-
(1993)
Diagn Mol Pathol
, vol.2
, pp. 241-247
-
-
Liu, J.1
Johnson, R.M.2
Traweek, T.3
-
9
-
-
0029144465
-
Clearance of PCR-detectable lymphoma cells from the peripheral blood, but not bone marrow, after therapy with Campath-1H
-
Dellekarth G, Laczika K, Scholten C, Lechner K, Laeger U, Schwarzinger I, Simonitsch I: Clearance of PCR-detectable lymphoma cells from the peripheral blood, but not bone marrow, after therapy with Campath-1H. Am J Hematol 50:146-147, 1995.
-
(1995)
Am J Hematol
, vol.50
, pp. 146-147
-
-
Dellekarth, G.1
Laczika, K.2
Scholten, C.3
Lechner, K.4
Laeger, U.5
Schwarzinger, I.6
Simonitsch, I.7
-
10
-
-
0027537357
-
Differential response in a patient treated with Campath-1H monoclonal antibody for refractory non-Hodgkin's lymphoma
-
Lim SH, Davey G, Marcus R: Differential response in a patient treated with Campath-1H monoclonal antibody for refractory non-Hodgkin's lymphoma. Lancet 341:432-433, 1993.
-
(1993)
Lancet
, vol.341
, pp. 432-433
-
-
Lim, S.H.1
Davey, G.2
Marcus, R.3
|